ID
27983
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: All visits. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (2)
- 12/7/17 12/7/17 -
- 1/1/18 1/1/18 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
December 7, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Radiotherapy GOAL Trial B-cell Lymphoma NCT02499003
Radiotherapy GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Description
Radiotherapy
Description
Radiotherapy number
Data type
integer
Description
N = Node, O = Organ
Data type
integer
Description
specification localisation
Data type
text
Description
Total dose radiotherapy
Data type
float
Measurement units
- Gy
Description
Start date
Data type
date
Description
End date
Data type
date
Description
Best response
Data type
integer
Similar models
Radiotherapy GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM